Pyxis Oncology (PYXS) Market Capitalization (2021 - 2026)

Pyxis Oncology (PYXS) has reported Market Capitalization for 6 consecutive years, with $190.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 179.89% year-over-year to $190.9 million in Q2 2026; TTM through Jun 2026 was $190.9 million, a 179.89% increase from a year earlier, with the FY2025 full-year figure at $72.1 million, down 22.94% from the prior year.
• Market Capitalization was $190.9 million for Q2 2026 at Pyxis Oncology, up from $72.1 million in the prior quarter.
• Over five years, Market Capitalization peaked at $250.5 million in Q1 2024 and troughed at $46.8 million in Q4 2022.
• A 5-year average of $119.0 million and a median of $93.5 million in 2024 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization tumbled 75.89% in 2025 and surged 179.89% in 2026, its largest moves.
• Over 5 years, Market Capitalization stood at $46.8 million in 2022, then soared by 71.97% to $80.6 million in 2023, then gained by 16.13% to $93.5 million in 2024, then dropped by 22.94% to $72.1 million in 2025, then surged by 164.85% to $190.9 million in 2026.
• The last three Market Capitalization figures came in at $190.9 million (Q2 2026), $72.1 million (Q4 2025), and $138.0 million (Q3 2025), per Business Quant data.